Kabell G
Division of Cardiology, University of Virginia Medical Center, Charlottesville.
Circulation. 1988 Jun;77(6):1385-94. doi: 10.1161/01.cir.77.6.1385.
Ventricular action potentials and longitudinal conduction times over short distances of epicardium were recorded in isolated rabbit hearts. Global ischemia produced a progressive decrease of resting membrane potential, depression of action potentials, and conduction slowing to approximately 50% of control values over 8 to 10 min. Verapamil (2 X 10(-6) M) markedly attenuated ischemia-induced conduction slowing in association with less depression of maximum upstroke velocity (Vmax) and slightly less change in resting membrane potential. In contrast, Bay K 8644 (10(-7) M), a calcium-channel agonist, exacerbated ischemia-induced conduction slowing and depression of Vmax but did not significantly affect resting membrane potential. Regression analysis of Vmax vs resting membrane potential and the square of conduction velocity vs Vmax demonstrated that verapamil and Bay K 8644 shifted these relationships in opposite directions. The results indicate that the calcium-channel activation state can modulate slowing of conduction during early ischemia. This is most likely due to alterations in calcium influx before and/or during ischemia. There appear to be three possible components to this effect: (1) a small alteration in the magnitude of ischemia-induced depolarization, (2) alterations of membrane responsiveness at depolarized values of resting membrane potential, and (3) alterations in "nonactive" components of conduction during ischemia, such as changes in excitability or cell-to-cell coupling.
在离体兔心脏中记录心室动作电位和心外膜短距离的纵向传导时间。整体缺血导致静息膜电位进行性降低、动作电位幅度降低以及在8至10分钟内传导速度减慢至对照值的约50%。维拉帕米(2×10⁻⁶ M)显著减轻缺血诱导的传导减慢,同时最大上升速度(Vmax)降低较少,静息膜电位变化也略小。相比之下,钙通道激动剂Bay K 8644(10⁻⁷ M)加剧了缺血诱导的传导减慢和Vmax降低,但对静息膜电位无显著影响。Vmax与静息膜电位以及传导速度的平方与Vmax的回归分析表明,维拉帕米和Bay K 8644使这些关系向相反方向移动。结果表明,钙通道激活状态可在早期缺血期间调节传导减慢。这很可能是由于缺血前和/或缺血期间钙内流的改变所致。这种效应似乎有三个可能的组成部分:(1)缺血诱导的去极化幅度的小改变,(2)静息膜电位去极化值时膜反应性的改变,以及(3)缺血期间传导的“非活性”成分的改变,如兴奋性或细胞间偶联的变化。